Sabrina Vari
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Oncology 20
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
-
- Sarcoma Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Francesco Cognetti (10 shared papers)Italia Falcone (5 shared papers)Ludovica Ciuffreda (5 shared papers)Michèle Milella (6 shared papers)Ursula Cesta Incani (4 shared papers)Anais Del Curatolo (4 shared papers)Fabiana Conciatori (3 shared papers)Vanja Vaccaro (3 shared papers)
- Journals
- Journal of Clinical Medicine (5 papers)Future Oncology (3 papers)Frontiers in Oncology (3 papers)International Journal of Molecular Sciences (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ItalyMalaysiaUnited States
In The Last Decade
Sabrina Vari
28 papers receiving 788 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 196
- Oncology 272
- Molecular Biology 435
- Pulmonary and Respiratory Medicine 186
- Genetics 41
Countries citing papers authored by Sabrina Vari
This map shows the geographic impact of Sabrina Vari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Vari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Vari more than expected).
Fields of papers citing papers by Sabrina Vari
This network shows the impact of papers produced by Sabrina Vari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Vari. The network helps show where Sabrina Vari may publish in the future.
Co-authors
The 25 scholars most cited alongside Sabrina Vari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 358 | |
| 2 | 2014 | 75 | |
| 3 | 2014 | 52 | |
| 4 | 2017 | 36 | |
| 5 | 2016 | 35 | |
| 6 | 2020 | 35 | |
| 7 | 2019 | 28 | |
| 8 | The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions. | 2013 | 22 |
| 9 | 2015 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2015 | 12 | |
| 14 | 2016 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2014 | 9 | |
| 18 | 2022 | 7 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 7 |
About Sabrina Vari
Sabrina Vari is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Urology, having authored 30 papers that have together received 800 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Cancer Treatment and Pharmacology (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Management of metastatic bone disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Cancer Research (196 citations), Oncology (272 citations), Molecular Biology (435 citations), Pulmonary and Respiratory Medicine (186 citations) and Genetics (41 citations). Sabrina Vari has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include Francesco Cognetti, Italia Falcone, Ludovica Ciuffreda, Michèle Milella, Ursula Cesta Incani, Anais Del Curatolo, Fabiana Conciatori, Vanja Vaccaro, Nicola Inzerilli and Carmen Nuzzo. Their work appears in journals such as Journal of Clinical Medicine, Future Oncology, Frontiers in Oncology, International Journal of Molecular Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.